We have developed a mouse model [1] in which previous (6 weeks) focal brain irradiation results in aggressive growth and non-responsiveness to anti-PD-L1 immunotherapy, mimicking recurrent GBM in the clinic. Here, CD274 is linked to glioblastoma.